IND 32095 is Immuron's Investigational new drug (IND) application for clinical development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI) and is now ...
Combining “complementary” audio technology could speed the adoption of the immersive Atmos sound format, a Dolby exec says. By Carolyn Giardina Tech Editor Dolby Laboratories has acquired rival ...
IMM-1-104 combined with mGnP shows promising efficacy and tolerability in first-line pancreatic cancer, with a 43% ORR and 86% DCR among seven patients. IMM-1-104 demonstrated target lesion shrinkage ...
Immuron to develop U.S. registration dossier for IMM-124E for Travelers' Diarrhea Company anticipates significant inflection in sales with successful FDA registration of IMM-124E Company to pursue ...
- IMM-1-104 Fast Track designation now granted for the treatment of both first and second-line pancreatic ductal adenocarcinoma (PDAC); provides potential to accelerate IMM-1-104’s path to U.S. FDA ...
Cardiac fibrosis, which is characterized by a net accumulation of extracellular matrix (ECM) in the myocardium [1, 2], is an integral component of most cardiac pathologic conditions and eventually ...
RAHWAY, N. J.--(BUSINESS WIRE)--CFM, IMM and NXTsoft, the leading provider of API connectivity, document workflow, teller workflow, and data analytics software, today announced 55 new financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results